Core Laboratories Nv Stock Current Valuation
| CLB Stock | USD 20.84 0.44 2.07% |
Valuation analysis of Core Laboratories helps investors to measure Core Laboratories' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of November 26, 2024, Enterprise Value Over EBITDA is expected to decline to 12.62. In addition to that, Enterprise Value Multiple is expected to decline to 12.62. Fundamental drivers impacting Core Laboratories' valuation include:
Price Book 3.9022 | Enterprise Value 1.2 B | Enterprise Value Ebitda 15.5411 | Price Sales 1.8715 | Forward PE 22.1729 |
Fairly Valued
Today
Please note that Core Laboratories' price fluctuation is not too volatile at this time. Calculation of the real value of Core Laboratories is based on 3 months time horizon. Increasing Core Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Core Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Core Stock. However, Core Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.84 | Real 21.51 | Target 23.25 | Hype 20.9 | Naive 19.68 |
The real value of Core Stock, also known as its intrinsic value, is the underlying worth of Core Laboratories Company, which is reflected in its stock price. It is based on Core Laboratories' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Core Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Core Laboratories NV helps investors to forecast how Core stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Core Laboratories more accurately as focusing exclusively on Core Laboratories' fundamentals will not take into account other important factors: Core Laboratories NV Company Current Valuation Analysis
Core Laboratories' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Core Laboratories Current Valuation | 1.15 B |
Most of Core Laboratories' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Core Laboratories NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Core Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Core Laboratories is extremely important. It helps to project a fair market value of Core Stock properly, considering its historical fundamentals such as Current Valuation. Since Core Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Core Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Core Laboratories' interrelated accounts and indicators.
Click cells to compare fundamentals
Core Current Valuation Historical Pattern
Today, most investors in Core Laboratories Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Core Laboratories' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Core Laboratories current valuation as a starting point in their analysis.
Core Laboratories Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Core Laboratories NV has a Current Valuation of 1.15 B. This is 97.05% lower than that of the Energy Equipment & Services sector and 94.94% lower than that of the Energy industry. The current valuation for all United States stocks is 93.07% higher than that of the company.
Core Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Core Laboratories' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Core Laboratories could also be used in its relative valuation, which is a method of valuing Core Laboratories by comparing valuation metrics of similar companies.Core Laboratories is currently under evaluation in current valuation category among its peers.
Core Laboratories ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Core Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Core Laboratories' managers, analysts, and investors.Environmental | Governance | Social |
Core Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0589 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 1.15 B | ||||
| Shares Outstanding | 46.95 M | ||||
| Shares Owned By Insiders | 0.85 % | ||||
| Shares Owned By Institutions | 99.15 % | ||||
| Number Of Shares Shorted | 6.95 M | ||||
| Price To Earning | 101.74 X | ||||
| Price To Book | 3.90 X | ||||
| Price To Sales | 1.87 X | ||||
| Revenue | 509.79 M | ||||
| Gross Profit | 96.08 M | ||||
| EBITDA | 70.42 M | ||||
| Net Income | 37.02 M | ||||
| Cash And Equivalents | 15.43 M | ||||
| Cash Per Share | 0.29 X | ||||
| Total Debt | 215.38 M | ||||
| Debt To Equity | 1.29 % | ||||
| Current Ratio | 2.23 X | ||||
| Book Value Per Share | 5.34 X | ||||
| Cash Flow From Operations | 24.79 M | ||||
| Short Ratio | 21.39 X | ||||
| Earnings Per Share | 0.54 X | ||||
| Price To Earnings To Growth | 1.86 X | ||||
| Target Price | 20.0 | ||||
| Number Of Employees | 3.5 K | ||||
| Beta | 2.36 | ||||
| Market Capitalization | 978.44 M | ||||
| Total Asset | 586.39 M | ||||
| Retained Earnings | 120.76 M | ||||
| Working Capital | 135.04 M | ||||
| Current Asset | 238.55 M | ||||
| Current Liabilities | 120.76 M | ||||
| Annual Yield | 0 % | ||||
| Five Year Return | 2.66 % | ||||
| Net Asset | 586.39 M | ||||
| Last Dividend Paid | 0.04 |
About Core Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Core Laboratories NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core Laboratories NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:Check out Core Laboratories Piotroski F Score and Core Laboratories Altman Z Score analysis. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.316 | Dividend Share 0.04 | Earnings Share 0.54 | Revenue Per Share 11.158 | Quarterly Revenue Growth 0.072 |
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.